Cns Pharmaceuticals, Inc. · NASDAQ:CNSP

Ikarian Capital, LLC reported a 5.70% stake in Cns Pharmaceuticals, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Apr 17, 2026

Ikarian Capital, LLC reported a 5.70% stake in Cns Pharmaceuticals, Inc., 45,830 shares, as a passive investor on Dec 31, 2025. Filed Apr 17, 2026 (Schedule 13G).

Stake
5.70%
Shares
45,830
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Ikarian Capital, LLC5.70%45,830
Neil Shahrestani5.70%45,830

Source

View original at SEC

Related